1. Catalogs
  2. Vivaproducts, Inc.
  3. VivafreeTM 500 and VivafreeTM 2

VivafreeTM 500 and VivafreeTM 2

VivafreeTM  500 and VivafreeTM 2

VivafreeTM 500 and VivafreeTM 2

Product catalog summary
Overview: Vivafree™ centrifugal filters are designed for the rapid and accurate separation of free drugs and hormones from those bound to serum or plasma proteins. These filters are particularly useful in therapeutic drug monitoring, drug binding studies, and sample preparation for mass spectrometry.
Applications:
  • Separation of free hormones such as testosterone, insulin, and cortisol.
  • Sample preparation for therapeutic drug monitoring of substances like phenytoin, valproic acid, and antibiotics.
  • Protein removal from samples prior to mass spectrometry.
  • Preparation for drug binding studies.
Features and Benefits:
  • Equipped with a low binding Hydrosart® membrane, ensuring high sample recoveries.
  • Centrifugal separation is significantly faster than equilibrium dialysis, taking approximately 30 minutes compared to 6-12 hours.
Technical Specifications:
  • Vivafree™ 500: Total sample capacity of 0.5 ml, with dimensions of 45 mm length for filtration and 47.5 mm for back-spin, and an active membrane area of 0.32 cm².
  • Vivafree™ 2: Total sample capacity of 2 ml, with dimensions of 125 mm length for filtration and 115 mm for back-spin, and an active membrane area of 0.95 cm².
  • Both models have a hold-up volume of less than 5 µl and 10 µl respectively, with no dead stop in swing-out rotors.
Materials of Construction: The body is made of polycarbonate, while the filtrate vessel and back spin vial are made of polypropylene. The membrane options include Hydrosart® (30,000 MWCO) and Cellulose Triacetate (125,000 MWCO).
Equipment Requirements: A centrifuge with either a fixed angle or swing-out rotor is required. The maximum speed varies depending on the molecular weight cutoff (MWCO) of the membrane.
Performance Characteristics: The document provides detailed performance data for various samples, including free insulin, piperacillin, tazobactam, linezolid, fluconazole, cortisol, phenytoin, and testosterone, with specific conditions for each.
Ordering Information: The filters are available in different pack sizes and MWCO options, with specific product codes for ordering.
Contact Information: Manufactured by Sartorius Stedim Lab Ltd., with North American distribution through Vivaproducts. Contact details and website information are provided for further inquiries and ordering.
See more

Catalog excerpts

VivafreeTM  500 and VivafreeTM 2-1

Vivafree™ 500 and Vivafree™ 2Your Source for Clinical & Biological Concentrators Call us at 800-456-4633Rapid separation of free drugs and hormones Technical Specifications Concentrator Capacity Vivafree™ 500 Vivafree™ 2 Total Length (Filtration) 45 mm 125 mm Total Length (Back-spin) 47.5 mm 115 mm Dead stop volume Fixed angle rotor 5 pl 55 pl Swing out rotor No dead stop No dead stop Vivafree™ centrifugal filters offer a fast, accurate solution for separation of free drugs and hormones from those bound to serum or plasma proteins. The devices are useful for preparing samples for therapeutic drug monitoring, new drug binding studies and before mass spectrometry. Vivafree™ filters have been used for separating free hormones such as testosterone and insulin as well as drugs such as phenytoin, valproic acid and antibiotics. They are equipped with the patented regenerated cellulose Hydrosart® membrane which is designed to minimize binding of any microsolutes. Separations can be performed as quickly as 20 minutes with high recoveries and excellent reproducibility. Vivafree™ filters are single use devices intended for in vitro diagnostic (IVD) applications . Filtrate vessel Back spin vial Filtration cap Membrane12 O-ring Polycarb. = Polycarbonate, Polyprop. = Polypropylene *HY = Hydrosart® (30,000 MWCO) CTA = Cellulose Triacetate (125,000 MWCO) Equipment Required Vivafree™ Applications • Separation of free hormones (testosterone, insulin, cortisol). • Sample preparation for therapeutic drug monitoring (phenytoin, valproic acid, antibiotics, immunosuppressants). • Removal of proteins from samples before mass spectrometry. • Sample preparation for drug binding studies. Features Benefits Low binding membrane High recoveries of samples Centrifugal separation Much faster than equilibrium dialysis Rotor type Fixed angle or swing out2 conical bottom bottom tubes Maximum Speed Filtration rates in swing out rotors are typically 2-3 times slower

 Open the catalog to page 1
VivafreeTM  500 and VivafreeTM 2-2

Performance Characteristics (ah data from fixed angle rotors) Sample Initial Filtrate Centrifugal Device Type MWCO (all from serum) Volume Volume Time Temp. Force (xg) Vivafree™ 500 125,000 Free Insulin 500 pl 150 pl 30 min. 37o C 2,000 Vivafree™ 500 30,000 Free Piperacillin 500 pl 100 pl 30 min. 25o C 2,500 Vivafree™ 500 30,000 Free Tazobactam 500 pl 100 pl 30 min. 25o C 2,500 Vivafree™ 500 30,000 Free Linezolid 500 pl 90 pl 20 min. 37o C 1,000 Vivafree™ 500 30,000 Free Fluconazole 500 pl 90 pl 20 min. 37o C 1,000 Vivafree™ 2 30,000 Free Cortisol 500 pl 100 pl 20 min. 37o C 2,500 Vivafree™ 2...

 Open the catalog to page 2

All Vivaproducts, Inc. catalogs and technical brochures

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.